iroko


Also found in: Wikipedia.
Related to iroko: iroko tree

iroko

(ɪˈrəʊkəʊ)
n, pl -kos
1. (Plants) a tropical African hardwood tree of the genus Chlorophora. Also called: mvule
2. the hard reddish-brown wood of this tree
[C19: from Yoruba]
Mentioned in ?
References in periodicals archive ?
The Iroko program aims to use the proprietary SoluMatrix[TM] technology to lower the dosing of NSAIDs, reduce systemic exposure by 20%, and thus improve their safety and tolerability while maintaining their effectiveness.
Food preparation is simplified with a custom-fitted solid Iroko wood cutting board and the stainless bottom grid helps to prevent scratches from blemishing the bottom of the sink, ensuring the sink's beauty can be showcased for years to come.
A Global Witness spokesman says a survey of 130 retailers and wholesalers of hardwood garden furniture last month showed that most of the wood came from countries with question marks over sourcing of timber such as teak, iroko and nyatoh.
On the south are Bernardos slate and grey steel, To the north is concrete and iroko against the square.
The sink supports a bottom grid for draining, a top grid to raise the work surface, and a distinctive cutting board made of replenishable Iroko wood.
Other special features include iroko joinery, known for its hardwearing qualities and specially sourced for the new windows, doors and staircases.
In the original vernacular, the ribs are of palm saplings; in Piano's (much larger) reinterpretation of the forms, thay are made of laminated iroko, structurally linked by horizontal tubes and diagonal rod ties of stainless steel.
PHILADELPHIA -- Iroko Pharmaceuticals announced today the sale of its oral antibiotic product, Vancocin([R]) (vancomycin hydrochloride), to Merus Labs International Inc.
Key market players covered are BioDelivery Sciences International, Cephalon Inc, Iroko Pharmaceuticals, LLC, Novartis AG, SantoSolve AS and Winston Pharmaceuticals, Inc.
Under the services agreement, Aptuit will produce for Iroko Phase III supplies of lower dose, nanotechnology formulations for multiple nonsteroidal anti-inflammatory drugs (NSAIDs).
Key market players covered are BioDelivery Sciences International, Cephalon Inc, Iroko Pharmaceuticals,LLC, Novartis AG, SantoSolve AS and Winston Pharmaceuticals, Inc.